Stability of extemporaneously prepared glycopyrrolate oral suspensions

American Journal of Health-System Pharmacy

Volumn 68, Issue 9, 2011, Pages 843-845

  Cober, Mary Petrea ^a,b   Johnson, Cary E ^c,d   Sudekum, David ^c   Penprase, Kimberly ^c  

^a AKRON CHILDREN'S HOSPITAL   (United States)

^b NORTHEAST OHIO MEDICAL UNIVERSITY   (United States)

^c Department of Pharmacy Practice   (United States)

^d UMHHC   (United States)

Author keywords

Chromatography, liquid; Color; Compounding; Concentration; Contamination; Glycopyrrolate; Hydrogen ion concentration; Parasympatholytic agents; Stability; Storage; Suspensions; Taste; Vehicles

Indexed keywords

GLYCOPYRRONIUM BROMIDE;

ARTICLE; CONCENTRATION (PARAMETERS); DILUTION; DRUG FORMULATION; DRUG STABILITY; DRUG SYNTHESIS; GRINDING; HIGH PERFORMANCE LIQUID CHROMATOGRAPHY; MICROBIAL GROWTH; MICROPIPETTE; PH MEASUREMENT; PRIORITY JOURNAL; ROOM TEMPERATURE; SUSPENSION; TASTE;

EID: 79956028479     PISSN: 10792082     EISSN: 15352900     Source Type: Journal    
DOI: 10.2146/100247     Document Type: Article

References (6)

1. Tscheng DZ. Sialorrhea-therapeutic drug options. Ann Pharmacother. 2002; 36:1785-90.
2. Bachrach SJ, Walter RS, Trzcinski K. Use of glycopyrrolate and other anticholinergic medications for sialorrhea in children with cerebral palsy. Clin Pediatr. 1998; 37:485-90. (Pubitemid 28378245)
3. Mier RJ, Bachrach SJ, Lakin RC et al. Treatment of sialorrhea with glycopyrrolate: a double-blind, dose ranging study. Arch Pediatr Adolesc Med. 2000; 154:1214-8.
4. Robb AS, Lee RH, Cooper EB et al. Glycopyrrolate for treatment of clozapineinduced sialorrhea in three adolescents. J Child Adolesc Psychopharmacol. 2008; 18:99-107. (Pubitemid 351311241)
5. Jappinen A, Kokki H, Naaranlahti TJ et al. Stability of buprenorphine, haloperidol and glycopyrrolate mixture in a 0.9% sodium chloride solution. Pharm World Sci. 1999; 21:272-4. (Pubitemid 30041080)
6. Lexi-Comp. Glycopyrrolate: pediatric drug information. www.uptodate.com (accessed 2010 Jun 22).